T CELL HYBRIDOMA LYMPHOKINE CHEMOTACTIC FOR T LYMPHOCYTE
T 细胞杂交瘤淋巴细胞趋化因子
基本信息
- 批准号:3445887
- 负责人:
- 金额:$ 4.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-07-01 至 1989-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Local T lymphocyte accumulation is thought to be important for tumor
rejection and may presage local autoimmune disease and rejection of
transplanted organs. The mechanisms of T lymphocyte accumultion at the
site of initial antigen stimulation are not well defined, but it is known
that antigen stimulated T cells produce a lymphokine(s) that is (are)
chemotactic for other T cells.
It is proposed that several different lymphokines that specifically attract
either helper/inducer or suppressor/cytotoxic T cells may be released at
different times and perhaps by different T lymphocyte subpopulations
throughout the course of a local inflammatory response. Further, it is
probable that these lymphokines play a significant role in determining the
lymphocyte subpopulations that accumulate in a local inflammatory response
and thereby, modulate the immune response.
A T cell hybridoma, FS730.11, that produces large amounts of T cell
specific lymphocyte chemotactic factor (LCF), but only a restricted range
of other lymphokines has been developed. Con A stimulated supernate from
cultures of FS730.11 will be used as a source of LCF from a single cell
type to define whether helper or suppressor T cell subpopulations respond
to this particular LCF. Helper and suppressor T cell subpopulations will
be obtained by plating nylon wool non-adherent, mouse spleen cells on rat
monoclonal anti-Lyt1 or Lyt2 antibody-coated plastic tissue culture
plates. The purity of cell subpopulations will be assessed by flow
cytrometry. Chemotaxis of these T cell subpopulations, in response to LCF,
will then be assessed by migration through 8 micron pore size
nitrocellulose filters in modified blindwell Boyden chambers.
Semi-purified LCF will be injected into the peritoneum of mice. The
peritoneal exudate cells will be quantified, differentiated by hematoxylin
staining, and evaluated by flow cytometry for T lymphocyte.
Purification of LCF will be initiated by sequential ultrafiltration and
high performance liquid chromatography (HPLC). LCF will be characterized
by sensitivity to inactivation with several enzymes, by disc gel
electrophoresis, by isoelectric focusing and by column chromatography.
Antibody to purified mouse LCF will be produced in rats. Intrinsically,
radiolabelled LCF will be produced by Con A stimulation of FS730.11 in
tissue culture, and a radioimmunoassay (RIA) for LCF developed. This RIA
will facilitate future experiments to determine the T cell subpopulation(s)
source of LCF and the kinetics of LCF production. A rat B cell hybridoma
that secretes anti-LCF antibody will be produced, and antibody from that B
cell hybridoma will be used in future experiments to study modulation of
the immune response by inhibiting LCF activity in vivo.
局部T淋巴细胞积聚被认为是肿瘤的重要因素
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY H HILL其他文献
JEFFREY H HILL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY H HILL', 18)}}的其他基金
T CELL HYBRIDOMA LYMPHOKINE CHEMOTACTIC FOR T LYMPHOCYTE
T 细胞杂交瘤淋巴细胞趋化因子
- 批准号:
3445888 - 财政年份:1986
- 资助金额:
$ 4.84万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 4.84万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
- 批准号:
23K06940 - 财政年份:2023
- 资助金额:
$ 4.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)